Bridgebio Pharma Stock Pattern Recognition Harami Cross Pattern
| BBIO Stock | USD 75.21 2.97 3.80% |
| Symbol |
Recognition |
The output start index for this execution was eleven with a total number of output elements of fifty. The function generated a total of two valid pattern recognition events for the selected time horizon. The Harami Cross pattern describes BridgeBio Pharma bullish reversal trend.
BridgeBio Pharma Technical Analysis Modules
Most technical analysis of BridgeBio Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BridgeBio from various momentum indicators to cycle indicators. When you analyze BridgeBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BridgeBio Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BridgeBio Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of BridgeBio Pharma based on widely used predictive technical indicators. In general, we focus on analyzing BridgeBio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BridgeBio Pharma's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of BridgeBio Pharma's intrinsic value. In addition to deriving basic predictive indicators for BridgeBio Pharma, we also check how macroeconomic factors affect BridgeBio Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2025 | 2026 (projected) | Dividend Yield | 3.11E-4 | 3.98E-4 | Price To Sales Ratio | 26.46 | 25.14 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BridgeBio Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Will Biotechnology sector continue expanding? Could BridgeBio diversify its offerings? Factors like these will boost the valuation of BridgeBio Pharma. Projected growth potential of BridgeBio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BridgeBio Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.21) | Revenue Per Share | Quarterly Revenue Growth 43.18 | Return On Assets | Return On Equity |
BridgeBio Pharma's market price often diverges from its book value, the accounting figure shown on BridgeBio's balance sheet. Smart investors calculate BridgeBio Pharma's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since BridgeBio Pharma's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between BridgeBio Pharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BridgeBio Pharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, BridgeBio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.